Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Bertilsson

Showing results (121-130 of 263) with videos related to

Pageof 27
Sort By:
Clinical Pharmacology and Therapeutics|January 1, 1980
Autoinduction of carbamazepine metabolism in children examined by a stable isotope techniqueL Bertilsson, B Höjer, G Tybring, et al.
Archives of Neurology|November 1, 1980
Carbamazepine therapy in trigeminal neuralgia: clinical effects in relation to plasma concentrationT Tomson, G Tybring, L Bertilsson, et al.
Regulatory Peptides|March 27, 1990
N-terminally extended substance P is released together with substance P from rat spinal cordG Toresson, C de las Carreras, L Bertilsson, et al.
European Journal of Clinical Pharmacology|June 22, 2001
CYP2C19 polymorphism is not important for the in vivo metabolism of selegilineK Laine, M Anttila, L Nyman, et al.
British Journal of Clinical Pharmacology|December 3, 1999
Ketoconazole inhibits the metabolism of tolterodine in subjects with deficient CYP2D6 activityN Brynne, C Forslund, B Hallén, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 1, 1976
Reduction of tryptophan hydroxylase activity and 5-hydroxytryptamine concentration in certain rat brain nuclei after p-chloroamphetamineL M Neckers, L Bertilsson, S H Koslow, et al.
Therapeutic Drug Monitoring|July 1, 1990
Slow omeprazole metabolizers are also poor S-mephenytoin hydroxylatorsT Andersson, C G Regårdh, M L Dahl-Puustinen, et al.
British Journal of Clinical Pharmacology|January 1, 1994
Disposition of clozapine in man: lack of association with debrisoquine and S-mephenytoin hydroxylation polymorphismsM L Dahl, A Llerena, U Bondesson, et al.
Acta Psychiatrica Scandinavica|March 1, 1985
Alaproclate a novel antidepressant? A biochemical and clinical comparison with zimeldineA Aberg-Wistedt, M Alvariza, L Bertilsson, et al.
Therapeutic Drug Monitoring|January 1, 1988
Alprazolam does not inhibit the metabolism of nortriptyline in depressed patients or inhibit the metabolism of desipramine in human liver microsomesL Bertilsson, A Aberg-Wistedt, A Lidén, et al.
Pageof 27

Showing results (121-130 of 263) with videos related to

Sort By:
Pageof 27
Clinical Pharmacology and Therapeutics|January 1, 1980
Autoinduction of carbamazepine metabolism in children examined by a stable isotope techniqueL Bertilsson, B Höjer, G Tybring, et al.
Archives of Neurology|November 1, 1980
Carbamazepine therapy in trigeminal neuralgia: clinical effects in relation to plasma concentrationT Tomson, G Tybring, L Bertilsson, et al.
Regulatory Peptides|March 27, 1990
N-terminally extended substance P is released together with substance P from rat spinal cordG Toresson, C de las Carreras, L Bertilsson, et al.
European Journal of Clinical Pharmacology|June 22, 2001
CYP2C19 polymorphism is not important for the in vivo metabolism of selegilineK Laine, M Anttila, L Nyman, et al.
British Journal of Clinical Pharmacology|December 3, 1999
Ketoconazole inhibits the metabolism of tolterodine in subjects with deficient CYP2D6 activityN Brynne, C Forslund, B Hallén, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 1, 1976
Reduction of tryptophan hydroxylase activity and 5-hydroxytryptamine concentration in certain rat brain nuclei after p-chloroamphetamineL M Neckers, L Bertilsson, S H Koslow, et al.
Therapeutic Drug Monitoring|July 1, 1990
Slow omeprazole metabolizers are also poor S-mephenytoin hydroxylatorsT Andersson, C G Regårdh, M L Dahl-Puustinen, et al.
British Journal of Clinical Pharmacology|January 1, 1994
Disposition of clozapine in man: lack of association with debrisoquine and S-mephenytoin hydroxylation polymorphismsM L Dahl, A Llerena, U Bondesson, et al.
Acta Psychiatrica Scandinavica|March 1, 1985
Alaproclate a novel antidepressant? A biochemical and clinical comparison with zimeldineA Aberg-Wistedt, M Alvariza, L Bertilsson, et al.
Therapeutic Drug Monitoring|January 1, 1988
Alprazolam does not inhibit the metabolism of nortriptyline in depressed patients or inhibit the metabolism of desipramine in human liver microsomesL Bertilsson, A Aberg-Wistedt, A Lidén, et al.
Pageof 27